Evidence map›Paper›PMID 29755564›Full record

ArticleIranian journal of pharmaceutical research : IJPR2018

A New Taraxastane Triterpene from

Sara Shamsabadipour, Seyed Mohammad Zarei, Mustafa Ghanadian, Seyed Abdulmajid Ayatollahi, Mohammad Reza Rahimnejad, Hojjatollah Saeedi, Mahmoud Aghaei

Abstract read
In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. New Cytotoxic Premyrsinane-Type Diterpenes fromIranian journal of pharmaceutical research : IJPR · 2022
    Article
  4. Phytochemical Study ofMetabolites · 2022
    Article
  5. Article
  6. Review
  7. Trace Element Analysis by ICP-MS and Chemometric Approach in SomeIranian journal of pharmaceutical research : IJPR · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sara ShamsabadipourDepartment of Biology, Faculty of Science, University of Isfahan, Isfahan, I.R. Iran.
Seyed Mohammad ZareiPhytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, I.R. Iran.
Mustafa GhanadianIsfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, I.R. Iran.
Seyed Abdulmajid AyatollahiPhytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, I.R. Iran.
Mohammad Reza RahimnejadDepartment of Biology, Faculty of Science, University of Isfahan, Isfahan, I.R. Iran.
Hojjatollah SaeediDepartment of Biology, Faculty of Science, University of Isfahan, Isfahan, I.R. Iran.
Mahmoud AghaeiBiochemistry Department, Isfahan Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this research, aerial parts of

Indexed as

CycloartaneCytotoxicityEuphorbia denticulateProstate CancerTaraxastaneTriterpenes

Identifiers

PMID29755564
PMCPMC5937103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.